Search
Share your comments and feedback about ByMySide
Chemotherapy induced anemia
Register for the By My Side™ Cancer Support Network
 
Find out more about chemotherapy and different side effects associated with chemotherapy...
 
   

Ovarian Cancer

Ovarian cancer is the most deadly gynecologic cancer due to its tendency to be diagnosed at an advanced stage. In an attempt to change this, several cancer organizations have published a list of possible ovarian cancer symptoms.18 These symptoms include bloating, pelvic or abdominal pain, difficulty eating or feeling full quickly, or urinary symptoms (urgency or frequency). Women who experience these symptoms almost daily for more than a few weeks are encouraged to see a doctor, preferably a gynecologist.

Cancerous ovarian tumors can originate from cells covering or lining the ovaries, germ cells (cells that are destined to form eggs), or sex cord-stromal cells (cells that secrete hormones and connect the different structures of the ovaries). The majority of ovarian cancers develop from cells in the lining of the ovary.

Treatment of ovarian cancer varies by stage of the disease.

Stage I: Cancer is found in one or both of the ovaries.

Stage II: Cancer is found in the ovaries and has spread to the uterus (womb), the fallopian tubes, or other areas within the pelvis. Cancer cells may also be found in abdominal fluid.

Stage III: Cancer is found in the ovaries and has spread to other body locations within the abdomen, such as the surface of the liver, intestine or lymph nodes.

Stage IV: Cancer is found in the ovaries and has spread outside the abdomen or inside of the liver.

American Cancer Society: About Staging

Treatments for ovarian cancer include surgery and chemotherapy. In addition to systemic (whole-body) chemotherapy, patients with ovarian cancer may receive intraperitoneal chemotherapy. Intraperitoneal chemotherapy involves the administration of chemotherapy drugs directly into the abdominal cavity. It is important for patients to remember that treatment is determined by the stage and other specific characteristics of the cancer. Patients should speak with their doctor to discuss the individual risks and benefits of each treatment option.

 

Neulasta® (pegfilgrastim) is prescribed to reduce the risk of infection (initially marked by fever) in patients with some tumors receiving strong chemotherapy that decreases the number of infection-fighting white blood cells.

Important product safety information
Ruptured spleen (including fatal cases), serious allergic reactions, and a serious lung problem called acute respiratory distress syndrome have been reported. Call your doctor or seek emergency care right away if you have abdominal or shoulder tip pain, shortness of breath, trouble breathing, a fast rate of breathing, or any allergic reaction. The most common side effect of this injection is mild to moderate bone pain. If you have any questions about this information, be sure to discuss them with your doctor. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

By My Side™ - Caregiver Resource.   ® 2008 Amgen All rights reserved.
Amgen.com  |  Neulasta.com  |  Neupogen.com  |  Vectibix.com 
Terms of Use  |  Privacy Statement  |  Site Map